Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/FCF ratio high or low?
The EV/FCF ratio of 18.44x is 23% below its estimated 1-year average of 24.01x, near the low end of its estimated 1-year range (17.04x–32.63x).
As of 2026-10-06T16:07:55.370Z.
Calculation as of: 2026-10-06T16:07:55.370Z.
Quote observation: 2026-10-06T16:05:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a63c12ce7055b0216585e16b4e08b2fd6453147ab6d4be874ec80e726ee32667
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
18.44x
EV/FCF RATIO AVG TTM
N/A
EV/FCF RATIO AVG 3Y
N/A
EV/FCF RATIO AVG 5Y
N/A
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
24.83x
median of 183 covered companies
CURRENT VS SECTOR MEDIAN
-25.73%
vs the sector median at left
Market Cap
$135.45M
EV/FCF Ratio
246.17x
TTM Avg
151.93x
3Y Avg
133.72x
5Y Avg
94.60x
Market Cap
$136.88M
EV/FCF Ratio
500.37x
TTM Avg
1051.55x
3Y Avg
1051.55x
5Y Avg
1051.55x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Health Catalyst, Inc. (HCAT) | $131.43M | 18.44x | N/A | N/A | N/A |
| Organigram Global Inc. (OGI)vs › | $133.74M | N/A | N/A | N/A | N/A |
| Entera Bio Ltd. (ENTX)vs › | $128.40M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMD)vs › | $134.69M | N/A | 61.40x | 555.49x | 549.31x |
| Pyxis Oncology, Inc. (PYXS)vs › | $134.49M | N/A | N/A | N/A | N/A |
| AirSculpt Technologies, Inc. (AIRS)vs › | $135.45M | 246.17x | 151.93x | 133.72x | 94.60x |
| Freenome, Inc. (FRNM)vs › | $135.41M | N/A | N/A | N/A | N/A |
| KORU Medical Systems, Inc. (KRMD)vs › | $136.88M | 500.37x | 1051.55x | 1051.55x | 1051.55x |
| Atrium Therapeutics, Inc. (RNA)vs › | $136.85M | N/A | N/A | N/A | N/A |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $124.91M | N/A | N/A | N/A | N/A |
EV/FCF
18.4x
P/FCF
10.1x
FCF Yield
9.94%
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2026-10-05 | 18.34x |
| 2026-10-02 | 18.28x |
| 2026-10-01 | 18.00x |
| 2026-09-30 | 18.17x |
| 2026-09-29 | 18.28x |
| 2026-09-28 | 18.40x |
| 2026-09-25 | 18.23x |
| 2026-09-24 | 18.23x |
| 2026-09-23 | 18.11x |
| 2026-09-22 | 19.08x |
| 2026-09-21 | 18.62x |
| 2026-09-18 | 18.51x |
| 2026-09-17 | 18.57x |
| 2026-09-16 | 18.17x |
| 2026-09-15 | 18.11x |
| 2026-09-14 | 18.68x |
| 2026-09-11 | 18.00x |
| 2026-09-10 | 18.17x |
| 2026-09-09 | 18.17x |
| 2026-09-08 | 18.00x |
| 2026-09-04 | 17.95x |
| 2026-09-03 | 18.06x |
| 2026-09-02 | 17.95x |
| 2026-09-01 | 18.06x |
| 2026-08-31 | 17.66x |
| 2026-08-28 | 17.38x |
| 2026-08-27 | 17.38x |
| 2026-08-26 | 17.38x |
| 2026-08-25 | 17.32x |
| 2026-08-24 | 17.38x |
| 2026-08-21 | 17.04x |
| 2026-08-20 | 17.61x |
| 2026-08-19 | 17.95x |
| 2026-08-18 | 18.06x |
| 2026-08-17 | 18.00x |
| 2026-08-14 | 18.85x |
| 2026-08-13 | 18.28x |
| 2026-08-12 | 18.51x |
| 2026-08-11 | 18.34x |
| 2026-08-10 | 18.11x |
| 2026-08-07 | 18.17x |
| 2026-08-06 | 31.96x |
| 2026-08-05 | 32.63x |
| 2026-08-04 | 31.71x |
| 2026-08-03 | 31.13x |
| 2026-07-31 | 30.13x |
| 2026-07-30 | 30.05x |
| 2026-07-29 | 30.71x |
| 2026-07-28 | 30.55x |
| 2026-07-27 | 30.63x |
| 2026-07-24 | 30.05x |
| 2026-07-23 | 29.46x |
| 2026-07-22 | 29.71x |
| 2026-07-21 | 30.21x |
| 2026-07-20 | 30.71x |
| 2026-07-17 | 31.46x |
| 2026-07-16 | 31.71x |
| 2026-07-15 | 32.13x |
| 2026-07-14 | 31.80x |
| 2026-07-13 | 31.80x |
| 2026-07-10 | 31.80x |
| 2026-07-09 | 31.38x |
| 2026-07-08 | 31.05x |
| 2026-07-07 | 31.63x |
| 2026-07-06 | 31.80x |
| 2026-07-02 | 30.05x |
| 2026-07-01 | 29.96x |
| 2026-06-30 | 29.30x |
| 2026-06-29 | 29.05x |
| 2026-06-26 | 28.55x |
| 2026-06-25 | 27.46x |
| 2026-06-24 | 27.05x |
| 2026-06-23 | 27.38x |
| 2026-06-22 | 27.05x |
| 2026-06-18 | 27.21x |
| 2026-06-17 | 27.46x |
| 2026-06-16 | 27.55x |
| 2026-06-15 | 28.05x |
| 2026-06-12 | 28.13x |
| 2026-06-11 | 26.38x |
| 2026-06-10 | 26.05x |
| 2026-06-09 | 26.96x |
| 2026-06-08 | 27.30x |
| 2026-06-05 | 28.80x |
| 2026-06-04 | 28.88x |
| 2026-06-03 | 23.80x |
| 2026-06-02 | 23.96x |
| 2026-06-01 | 24.30x |
| 2026-05-29 | 24.21x |
| 2026-05-28 | 24.38x |
| 2026-05-27 | 23.55x |
| 2026-05-26 | 23.21x |
| 2026-05-22 | 23.46x |
| 2026-05-21 | 23.46x |
| 2026-05-20 | 23.46x |
| 2026-05-19 | 23.30x |
| 2026-05-18 | 23.30x |
| 2026-05-15 | 22.63x |
| 2026-05-14 | 22.46x |
| 2026-05-13 | 23.88x |
| 2026-05-12 | 25.05x |
